Drug: esomeprazole Quarter: 2016Q3
Total Drug/Injury Combinations: 283 Number of Pages: 15
DRUGNAME | PT | EventCount | |
---|---|---|---|
ESOMEPRAZOLE MYLAN//ESOMEPRAZOLE | Acute kidney injury | 1 | view events |
ESOMEPRAZOLE NAGNESIUM DELAYED-RELEASE CAPSULES, USP 40MG MYLAN | Dyspepsia | 1 | view events |
ESOMEPRAZOLE NAGNESIUM DELAYED-RELEASE CAPSULES, USP 40MG MYLAN | Nausea | 1 | view events |
ESOMEPRAZOLE NAGNESIUM DELAYED-RELEASE CAPSULES, USP 40MG MYLAN | Product substitution issue | 1 | view events |
ESOMEPRAZOLE PRESCRIPTION | Cardiac murmur | 1 | view events |
ESOMEPRAZOLE PRESCRIPTION | Injection site extravasation | 1 | view events |
ESOMEPRAZOLE PRESCRIPTION | Injection site haemorrhage | 1 | view events |
ESOMEPRAZOLE PRESCRIPTION | Off label use | 1 | view events |
ESOMEPRAZOLE SODIUM. | Condition aggravated | 1 | view events |
ESOMEPRAZOLE SODIUM. | Dermatitis | 1 | view events |
ESOMEPRAZOLE SODIUM. | Intentional product use issue | 1 | view events |
ESOMEPRAZOLE SODIUM. | Product use issue | 1 | view events |
ESOMEPRAZOLE SODIUM. | Pruritus | 1 | view events |
ESOMEPRAZOLE SODIUM. | Rash erythematous | 1 | view events |
ESOMEPRAZOLE SODIUM. | Rash morbilliform | 1 | view events |
ESOMEPRAZOLE W/NAPROXEN | IgA nephropathy | 1 | view events |
ESOMEPRAZOLE W/NAPROXEN | Inflammation | 1 | view events |
ESOMEPRAZOLE W/NAPROXEN | Liver disorder | 1 | view events |
ESOMEPRAZOLE W/NAPROXEN | Oedema | 1 | view events |
ESOMEPRAZOLE W/NAPROXEN | Vasculitic rash | 1 | view events |
Total Drug/Injury Combinations: 283 Number of Pages: 15
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)